• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗高血压药物反应的浓度-效应分析。

Concentration-effect analysis of antihypertensive drug responses.

作者信息

Reid J L, Meredith P A

机构信息

Department of Medicine and Therapeutics, University of Glasgow, Scotland.

出版信息

Hypertension. 1990 Jul;16(1):12-8. doi: 10.1161/01.hyp.16.1.12.

DOI:10.1161/01.hyp.16.1.12
PMID:2194941
Abstract

It is now widely recognized that a rigid stepped-care approach to antihypertensive therapy is not universally appropriate. Individualized treatment may result in good or better blood pressure control and a simpler regimen without troublesome side effects. Successful development of such a strategy depends on accurate characterization of a dose-response relation and quantitative assessment of the response in each individual. In the past such relations have proved to be hard to identify for antihypertensive drugs, often because of inappropriate study design during drug development. Despite failure of earlier studies to identify drug concentration-antihypertensive response relations, use of concentration-effect modeling, which recognizes and characterizes the temporal discrepancy between drug concentration and effect, has proved more successful. By using such approach, it has been possible to characterize the concentration-effect relations after acute and steady-state antihypertensive therapy with prazosin, doxazosin, nifedipine, verapamil, and enalapril. With enalapril and nifedipine, it has been demonstrated that the mathematical parameters of effect derived from the first dose can predict the response to these drugs after 4-6 weeks of treatment. These findings suggest that the definition of individual concentration-effect relations may be of value in the rational choice of antihypertensive drug therapy and optimization of dose and dose frequency. In particular, the approach can provide valuable information on dose-effect relations and should optimize choice of dose intervals in drug development and practice.

摘要

现在人们普遍认识到,采用严格的阶梯式降压治疗方法并非普遍适用。个体化治疗可能会使血压得到良好或更好的控制,治疗方案更简单,且无麻烦的副作用。制定这样一种策略的成功取决于准确描述剂量反应关系以及对每个个体反应的定量评估。过去,由于药物研发过程中研究设计不当,抗高血压药物的此类关系往往难以确定。尽管早期研究未能确定药物浓度与抗高血压反应的关系,但使用能够识别和描述药物浓度与效应之间时间差异的浓度效应模型已被证明更为成功。通过使用这种方法,已经能够描述哌唑嗪、多沙唑嗪、硝苯地平、维拉帕米和依那普利急性和稳态抗高血压治疗后的浓度效应关系。对于依那普利和硝苯地平,已经证明从首剂得出的效应数学参数可以预测治疗4至6周后对这些药物的反应。这些发现表明,个体浓度效应关系的定义可能有助于合理选择抗高血压药物治疗以及优化剂量和给药频率。特别是,该方法可以提供有关剂量效应关系的有价值信息,并应在药物研发和实践中优化给药间隔的选择。

相似文献

1
Concentration-effect analysis of antihypertensive drug responses.抗高血压药物反应的浓度-效应分析。
Hypertension. 1990 Jul;16(1):12-8. doi: 10.1161/01.hyp.16.1.12.
2
Antihypertensive drugs: individualized analysis and clinical relevance of kinetic-dynamic relationships.抗高血压药物:动力学-动态关系的个体化分析及临床相关性
Pharmacol Ther. 1992;53(1):67-79. doi: 10.1016/0163-7258(92)90044-z.
3
Concentration/effect analysis of antihypertensive drugs: single dose and steady state response to verapamil.抗高血压药物的浓度/效应分析:维拉帕米的单剂量和稳态反应
Int J Clin Pharmacol Ther Toxicol. 1992 Nov;30(11):507.
4
Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.抗高血压药物对自发性高血压大鼠肾血流量自动调节及肾小球毛细血管压力的影响。
Am J Physiol. 1998 Oct;275(4):F576-84. doi: 10.1152/ajprenal.1998.275.4.F576.
5
Concentration-effect analysis of antihypertensive drug response. Focus on calcium antagonists.抗高血压药物反应的浓度-效应分析。聚焦于钙拮抗剂。
Clin Pharmacokinet. 1994 Jun;26(6):472-85. doi: 10.2165/00003088-199426060-00005.
6
Dose-response clarification in early drug development.早期药物研发中的剂量-反应关系阐明
J Hypertens Suppl. 1991 Dec;9(6):S356-7.
7
Concentration-effect relationships and individual responses to doxazosin in essential hypertension.原发性高血压患者中多沙唑嗪的浓度-效应关系及个体反应
Br J Clin Pharmacol. 1989 Nov;28(5):517-26. doi: 10.1111/j.1365-2125.1989.tb03537.x.
8
Amlodipine; clinical relevance of a unique pharmacokinetic profile.氨氯地平;独特药代动力学特征的临床意义。
J Cardiovasc Pharmacol. 1993;22 Suppl A:S6-8.
9
A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.一项比较哌唑嗪控释片与依那普利治疗糖尿病高血压患者的随机、对照、多中心研究。孟买高血压研究组。
J Assoc Physicians India. 1998;Suppl 1:52-62.
10
[Evaluation of the efficacy and tolerance of doxazosin vs. enalapril inaged patients with light to moderate arterial hypertension].多沙唑嗪与依那普利治疗轻度至中度老年高血压患者的疗效和耐受性评估
Clin Ter. 1995 Dec;146(12):801-10.

引用本文的文献

1
Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats.在L-NAME高血压大鼠中,奈必洛尔在降低血压变异性和预防靶器官损伤方面比阿替洛尔更有效。
Hypertens Res. 2021 Jul;44(7):791-802. doi: 10.1038/s41440-021-00630-4. Epub 2021 Feb 22.
2
Enalapril clinical pharmacokinetics and pharmacokinetic-pharmacodynamic relationships. An overview.依那普利的临床药代动力学及药代动力学-药效学关系概述
Clin Pharmacokinet. 1993 Oct;25(4):274-82. doi: 10.2165/00003088-199325040-00003.
3
Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy.
血管紧张素转换酶(ACE)抑制剂治疗的药代动力学优化
Clin Pharmacokinet. 1992 May;22(5):375-84. doi: 10.2165/00003088-199222050-00004.
4
Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.依那普利。对其药理学及在高血压治疗中的应用的重新评估。
Drugs. 1992 Mar;43(3):346-81. doi: 10.2165/00003495-199243030-00005.